Tuli Saha
About Tuli Saha
Tuli Saha is a Director at Lyndra Therapeutics, where she has worked since 2023. She has held various roles in finance and administration, including Finance Manager and Associate Director of FP&A at the same company, and has a strong educational background with degrees from Northeastern University and Boston University.
Work at Lyndra Therapeutics
Tuli Saha has been serving as Director at Lyndra Therapeutics since 2023. Prior to this role, Saha held several positions within the company, including Associate Director of Financial Planning and Analysis (FP&A) from 2020 to 2023 and Finance Manager from 2018 to 2019. This progression demonstrates a strong commitment to the organization and a focus on financial management and strategic planning.
Education and Expertise
Tuli Saha earned a Master of Business Administration (MBA) from Northeastern University, completing the program in 2016. Prior to this, Saha obtained a Bachelor of Arts (BA) degree from Boston University, graduating in 2010. This educational background provides a foundation in business principles and financial analysis, contributing to expertise in finance and administration.
Background
Before joining Lyndra Therapeutics, Tuli Saha worked as an Administrative Associate at the Massachusetts Institute of Technology (MIT) from 2011 to 2016. This five-year experience at a prestigious institution contributed to Saha's administrative skills and understanding of organizational operations, which are essential in the roles held at Lyndra Therapeutics.
Career Progression
Tuli Saha's career at Lyndra Therapeutics reflects a steady advancement through various finance-related roles. Starting as Finance Manager in 2018, Saha transitioned to Associate Director of FP&A in 2020, and then to the current Director position in 2023. This trajectory indicates a deepening expertise in financial strategy and leadership within the organization.